Garassino, M. C.Kilickap, S.Ozguroglu, M.Sezer, A.Gumus, M.Bondarenko, I.Gogishvili, M.2024-06-122024-06-1220231556-08641556-1380https://hdl.handle.net/20.500.14551/26768[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Three-year Outcomes per PD-L1 Status and Continued Cemiplimab Beyond Progression plus Chemotherapy: EMPOWER-Lung 1Conference Object183E2E3N/AWOS:000989330100004